MedPath

Comparison of transport media s for detecting COVID-19 positivity.

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/12/029885
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age >= 18 years.

2. Asymptomatic patient planned for cancer surgery or any other procedure requiring general anaesthesia (DL Scopy/ cystoscopy/ PTBD/ PCN insertion).

3. Asymptomatic patient planned for in patient multiday chemotherapy in ward.

4. Symptomatic patient planned for COVID-19 swabbing by their treating physician.

5. Symptomatic staff planned for COVID-19 swabbing by the staff physician.

Exclusion Criteria

1. Participant not willing to participate in the study.

2. Participant on anticoagulation therapy or antiplatelet therapy for other ailments.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The difference between RT PCR COVID-19 positivity in samples transported in MTM and VTM media.Timepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
1. To assess the SARS Cov 2 positivity rate among symptomatic staff undergoing swabbing <br/ ><br>2. To compare the N gene/ E gene/ RaRP/ Orf1 positivity difference in MTM versus VTM media. <br/ ><br>3. Analyse potential impact of false negative patients difference.Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath